Incidence and Clinical Impact of Dual Nonresponsiveness to Aspirin and Clopidogrel in Patients With Drug-Eluting Stents
Anna Maria Gori, MD*,
Rossella Marcucci, MD*,
Angela Migliorini, MD ,
Renato Valenti, MD ,
Guia Moschi, MD ,
Rita Paniccia, MD*,
Piergiovanni Buonamici, MD ,
Gian Franco Gensini, MD*, , ,
Ruben Vergara, MD ,
Rosanna Abbate, MD* and
David Antoniucci, MD ,*
* Department of Medical and Surgical Critical Care, University of Florence, Florence, Italy
Department of Cardiology, Careggi Hospital, Florence, Italy
Center Santa Maria agli Ulivi, Don Carlo Gnocchi Foundation, Istituto di Ricovero e Cura a Carattere Scientifico, Impruneta, Florence, Italy.

View larger version (11K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Kaplan-Meier Analysis
Kaplan-Meier analysis of drug-eluting stent thrombosis (A) and the composite of cardiac death and drug-eluting stent thrombosis (B) for dual responders, dual nonresponders, isolated aspirin nonresponders, and isolated clopidogrel nonresponders.
|
|
|